-
Je něco špatně v tomto záznamu ?
Meloxicam Carrier Systems Having Enhanced Release and Aqueous Wettability Prepared Using Micro-suspensions in Different Liquid Media
N. Marinko, P. Zámostný,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- celulosa MeSH
- kinetika MeSH
- laktosa MeSH
- meloxikam aplikace a dávkování chemie MeSH
- nanostruktury MeSH
- nosiče léků chemie MeSH
- povrchově aktivní látky MeSH
- rozpustnost MeSH
- suspenze MeSH
- uvolňování léčiv MeSH
- velikost částic MeSH
- Publikační typ
- časopisecké články MeSH
One of the conventional methods of alleviating the problem of poor drug solubility is the particle size reduction. The efficiency of this approach depends on successful formulation suppressing the drug agglomeration. The aim of this study was to circumvent the dissolution problems of model hydrophobic meloxicam drug (MLX) by using liquid media of different wetting capacity to comminute and formulate a rapidly dissolving carrier system without the use of surfactants. Micro-suspensions of MLX were prepared by ball milling, using water or n-Heptane as a liquid medium. The suspensions were used as granulation liquids to formulate granulate from microcrystalline cellulose and lactose mixture. The release kinetics from prepared granulates were studied using the USP-4 dissolution apparatus. Micro-suspensions prepared via wet milling in non-water liquid media exhibited a massive improvement of release rate compared with source meloxicam and they outperformed their water-milled counterparts. The release rates from those formulations, despite not comprising any surfactant, were comparable to those obtained by different authors using surfactant stabilized nanosuspension formulations. Thus, they can present an interesting formulation alternative for hydrophobic drugs that are dissolution limited.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025000
- 003
- CZ-PrNML
- 005
- 20201222155005.0
- 007
- ta
- 008
- 201125s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1208/s12249-020-01701-4 $2 doi
- 035 __
- $a (PubMed)32449139
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Marinko, Nikita $u Department of Organic Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague 6, Czech Republic.
- 245 10
- $a Meloxicam Carrier Systems Having Enhanced Release and Aqueous Wettability Prepared Using Micro-suspensions in Different Liquid Media / $c N. Marinko, P. Zámostný,
- 520 9_
- $a One of the conventional methods of alleviating the problem of poor drug solubility is the particle size reduction. The efficiency of this approach depends on successful formulation suppressing the drug agglomeration. The aim of this study was to circumvent the dissolution problems of model hydrophobic meloxicam drug (MLX) by using liquid media of different wetting capacity to comminute and formulate a rapidly dissolving carrier system without the use of surfactants. Micro-suspensions of MLX were prepared by ball milling, using water or n-Heptane as a liquid medium. The suspensions were used as granulation liquids to formulate granulate from microcrystalline cellulose and lactose mixture. The release kinetics from prepared granulates were studied using the USP-4 dissolution apparatus. Micro-suspensions prepared via wet milling in non-water liquid media exhibited a massive improvement of release rate compared with source meloxicam and they outperformed their water-milled counterparts. The release rates from those formulations, despite not comprising any surfactant, were comparable to those obtained by different authors using surfactant stabilized nanosuspension formulations. Thus, they can present an interesting formulation alternative for hydrophobic drugs that are dissolution limited.
- 650 _2
- $a celulosa $7 D002482
- 650 _2
- $a nosiče léků $x chemie $7 D004337
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a laktosa $7 D007785
- 650 _2
- $a meloxikam $x aplikace a dávkování $x chemie $7 D000077239
- 650 _2
- $a nanostruktury $7 D049329
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a povrchově aktivní látky $7 D013501
- 650 _2
- $a suspenze $7 D013535
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zámostný, Petr $u Department of Organic Technology, University of Chemistry and Technology, Technická 5, 166 28, Prague 6, Czech Republic. petr.zamostny@vscht.cz.
- 773 0_
- $w MED00008281 $t AAPS PharmSciTech $x 1530-9932 $g Roč. 21, č. 5 (2020), s. 155
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32449139 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155001 $b ABA008
- 999 __
- $a ok $b bmc $g 1599145 $s 1115686
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 5 $d 155 $e 20200524 $i 1530-9932 $m AAPS PharmSciTech $n AAPS PharmSciTech $x MED00008281
- LZP __
- $a Pubmed-20201125